The behavioural effects of corticotropin releasing factor related peptides in rats

被引:103
作者
Jones, DNC [1 ]
Kortekaas, R [1 ]
Slade, PD [1 ]
Middlemiss, DN [1 ]
Hagan, JJ [1 ]
机构
[1] SmithKline Beecham Pharmaceut PLC, Neurosci Res, Harlow CM19 5AW, Essex, England
关键词
sauvagine; urotensin I; corticotropin-releasing factor; urocortin; hypophagia; anxiogenesis; hyperactivity;
D O I
10.1007/s002130050654
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study determined the behavioural effects of the corticotropin releasing factor (CRF)-related peptides, human/rat CRF (h/rCRF), ovine CRF (oCRF), sauvagine (SAUV), urotensin I(UT) and the recently discovered neuropeptide, rat urocortin (rUCN). All of the peptides dose-dependently increased motor activity in a familiar environment and reduced feeding in hungry rats. There was no apparent relationship between potency/affinity at CRF2 receptors and effects in these two tests. In a comparison of h/rCRF and rUCN upon discrete spontaneous behaviours, both peptides (3.0 mu g ICV) increased activity and grooming, induced a fore-paw tremor and reduced the incidence of motionlessness. However, h/rCRF reduced motionlessness to a greater extent and was a more potent inducer of defaecation, weight loss, oral movements and fore-paw tremor than rUCN. In the elevated X maze, both h/rCRF and rUCN (1.0 mu g ICV) had anxiogenic-like effects upon behaviour. In contrast, h/rCRF (1.0 mu g ICV), but not rUCN (1.0-10 mu g ICV) increased the startle response to an acoustic stimulus. In summary, all the CRF-related peptides increased motor activity and reduced feeding in rats in a similar manner and both rUCN and h/rCRF induced anxio-genesis. However, there were some behavioural differences between rUCN and h/rCRF which require further study. Further pharmacological investigation of the role of CRF receptor subtypes requires the use of subtype selective antagonists.
引用
收藏
页码:124 / 132
页数:9
相关论文
共 39 条
  • [1] THE EFFECTS OF CRF AND ALPHA-HELICAL CRF ON ANXIETY IN NORMAL AND HYPOPHYSECTOMIZED RATS
    ADAMEC, RE
    MCKAY, D
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 1993, 7 (04) : 346 - 354
  • [2] Behan DP, 1996, BRAIN RES, V725, P263, DOI 10.1016/S0006-8993(96)00347-2
  • [3] A COMPARISON OF THE BEHAVIORAL-EFFECTS OF CRF, SAUVAGINE AND UROTENSIN-I
    BRITTON, DR
    HOFFMAN, DK
    LEDERIS, K
    RIVIER, J
    [J]. BRAIN RESEARCH, 1984, 304 (02) : 201 - 205
  • [4] CORTICOTROPIN RELEASING-FACTOR (CRF) RECEPTOR ANTAGONIST BLOCKS ACTIVATING AND ANXIOGENIC ACTIONS OF CRF IN THE RAT
    BRITTON, KT
    LEE, G
    VALE, W
    RIVIER, J
    KOOB, GF
    [J]. BRAIN RESEARCH, 1986, 369 (1-2) : 303 - 306
  • [5] Corticotrophin-releasing factor receptors: From molecular biology to drug design
    Chalmers, DT
    Lovenberg, TW
    Grigoriadis, DE
    Behan, DP
    DeSouza, EB
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (04) : 166 - 172
  • [6] CHAPPELL PB, 1986, J NEUROSCI, V6, P2908
  • [7] COLDWELL MC, 1997, BR J PHARM S, V120, P364
  • [8] THE ROLE OF THE AMYGDALA IN FEAR AND ANXIETY
    DAVIS, M
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 1992, 15 : 353 - 375
  • [9] DESOUZA EB, 1995, ANNU REP MED CHEM, V30, P21
  • [10] Cloning and characterization of human urocortin
    Donaldson, CJ
    Sutton, SW
    Perrin, MH
    Corrigan, AZ
    Lewis, KA
    Rivier, JE
    Vaughan, JM
    Vale, WW
    [J]. ENDOCRINOLOGY, 1996, 137 (05) : 2167 - 2170